First Patient Dosed in ProstACT Program for Prostate Cancer Therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/30/2026

1. META
2. MSFT
3. FTNT
4. QCOM
5. ARM
6. SBUX
7. CVNA
8. TENB
9. SPY
10. CMG

Go back to First Patient Dosed in ProstACT Program for Prostate Cancer Therapy
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.02 -0.08 (0.79%)
Previous Close $10.10    52 Week High $2.18 
Open $10.04    52 Week Low $0.30 
Day High $10.04    P/E N/A 
Day Low $9.94    EPS $-3.32 
Volume 31,834